Pediatric Sickle Cell Disease Patients on Hydroxyurea Have Higher Rates of Surgical Splenectomy.

MLA

Menchaca, Alicia D., et al. “Pediatric Sickle Cell Disease Patients on Hydroxyurea Have Higher Rates of Surgical Splenectomy.” Journal of Surgical Research, vol. 283, Mar. 2023, pp. 798–805. EBSCOhost, https://doi.org/10.1016/j.jss.2022.11.026.

APA

Menchaca, A. D., Style, C. C., Villella, A. D., Burdjalov, M., Beyene, T. J., Minneci, P. C., & Olutoye, O. O. (2023). Pediatric Sickle Cell Disease Patients on Hydroxyurea Have Higher Rates of Surgical Splenectomy. Journal of Surgical Research, 283, 798–805. https://doi.org/10.1016/j.jss.2022.11.026

Chicago

Menchaca, Alicia D., Candace C. Style, Anthony D. Villella, Maria Burdjalov, Tariku J. Beyene, Peter C. Minneci, and Oluyinka O. Olutoye. 2023. “Pediatric Sickle Cell Disease Patients on Hydroxyurea Have Higher Rates of Surgical Splenectomy.” Journal of Surgical Research 283 (March): 798–805. doi:10.1016/j.jss.2022.11.026.